Epidemiologic aspects of cancer prevention in Germany

被引:0
|
作者
Nikolaus Becker
机构
[1] German Cancer Research Center,
[2] Division of Clinical Epidemiology,undefined
[3] Im Neuenheimer Feld 280,undefined
[4] 69120 Heidelberg,undefined
[5] Germany e-mail: n.becker@dkfz-heidelberg.de Tel.: +49-6221-422385; Fax: +49-6221-422203,undefined
关键词
Key words Attributable risk; Avoidable deaths; Cancer; Epidemiology; Prevention;
D O I
暂无
中图分类号
学科分类号
摘要
In Germany, as in other highly industrialized countries, cancer is the second most common cause of death. With approximately 210,000 individuals dying each year from malignant tumours, roughly one in four deaths in Germany can currently be attributed to cancer. Only in the past few years has there been a slow decline in the age-standardized mortality rates for cancer, even among men. This follows a long period of some decades, during which the mortality steadily increased and then persisted at a high level. The reversal, however, does not mean that the situation is no longer a cause for concern. In fact, for the most common cause of death, namely the cardiovascular diseases, a much greater decrease in mortality has been observed for many years now. If this trend continues, cancer could become the largest killer in another 15 to 20 years. On the other hand, we have been aware since the end of the 1960s that the majority of cancers are caused by environmental influences and are thus, in principle, avoidable. In the present contribution we present: (a) the fundamental arguments to support the thesis that a large proportion of cancers, and of cancer deaths, could be avoided; and (b) an estimate for Germany of both the theoretical potential of primary cancer prevention and also the practically attainable potential. The estimates are based on very conservative assumptions. They yield, for the theoretical potential, values in the range 43–65% and for the reduction actually obtainable in the medium term due to primary prevention, values of 18–31%.
引用
收藏
页码:9 / 19
页数:10
相关论文
共 50 条
  • [41] EPIDEMIOLOGIC ASPECTS
    DESMONTS, JM
    BAILLIERES CLINICAL ANAESTHESIOLOGY, 1992, 6 (03): : 463 - 475
  • [42] VITAMIN-C AND CANCER PREVENTION - THE EPIDEMIOLOGIC EVIDENCE
    BLOCK, G
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1991, 53 (01): : S270 - S282
  • [43] EPIDEMIOLOGIC EVIDENCE FOR BETA-CAROTENE AND CANCER PREVENTION
    VANPOPPEL, G
    GOLDBOHM, RA
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1995, 62 (06): : 1393 - 1402
  • [44] FRUIT, VEGETABLES, AND CANCER PREVENTION - A REVIEW OF THE EPIDEMIOLOGIC EVIDENCE
    BLOCK, G
    PATTERSON, B
    SUBAR, A
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1992, 18 (01): : 1 - 29
  • [45] Re: Interpreting epidemiologic studies of colorectal cancer prevention
    Hermann Brenner
    Michael Hoffmeister
    European Journal of Epidemiology, 2024, 39 : 97 - 97
  • [46] Epidemiological aspects of cancer screening in Germany
    Becker, N
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (12) : 691 - 702
  • [47] Epidemiological aspects of cancer screening in Germany
    Nikolaus Becker
    Journal of Cancer Research and Clinical Oncology, 2003, 129 : 691 - 702
  • [48] Future of colon cancer prevention in Germany
    Birkner, Berndt
    GASTROENTEROLOGIE, 2024, 19 (01): : 72 - 74
  • [49] Epidemiologic aspects and laboratory features of enterovirus infections in Western Germany, 2000-2005
    Roth, Bernhard
    Enders, Martin
    Arents, Annette
    Pfitzner, Artur
    Terletskaia-Ladwig, Elena
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (07) : 956 - 962
  • [50] RELATION BETWEEN THE HORMONAL AND EPIDEMIOLOGIC ASPECTS OF ESOPHAGEAL CANCER IN JAPAN
    KODAMA, M
    KODAMA, T
    TAKAGI, I
    KODAMA, M
    ANTICANCER RESEARCH, 1992, 12 (05) : 1671 - 1681